Correlation Between Oric Pharmaceuticals and Erasca

Can any of the company-specific risk be diversified away by investing in both Oric Pharmaceuticals and Erasca at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oric Pharmaceuticals and Erasca into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oric Pharmaceuticals and Erasca Inc, you can compare the effects of market volatilities on Oric Pharmaceuticals and Erasca and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oric Pharmaceuticals with a short position of Erasca. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oric Pharmaceuticals and Erasca.

Diversification Opportunities for Oric Pharmaceuticals and Erasca

0.73

Correlation Coefficient

Oric Pharmaceuticals  Erasca

Poor diversification

The 3 months correlation between Oric and Erasca is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Oric Pharmaceuticals and Erasca Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Erasca Inc and Oric Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oric Pharmaceuticals are associated (or correlated) with Erasca. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Erasca Inc has no effect on the direction of Oric Pharmaceuticals i.e., Oric Pharmaceuticals and Erasca go up and down completely randomly.

Pair Corralation between Oric Pharmaceuticals and Erasca

Given the investment horizon of 90 days Oric Pharmaceuticals is expected to generate 0.97 times more return on investment than Erasca. However, Oric Pharmaceuticals is 1.03 times less risky than Erasca. It trades about -0.04 of its potential returns per unit of risk. Erasca Inc is currently generating about -0.16 per unit of risk. If you would invest  896.00  in Oric Pharmaceuticals on October 12, 2024 and sell it today you would lose (46.00) from holding Oric Pharmaceuticals or give up 5.13% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Oric Pharmaceuticals  vs.  Erasca Inc

Oric Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oric Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's forward indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Erasca Inc

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Erasca Inc are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Erasca is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Oric Pharmaceuticals and Erasca

The main advantage of trading using opposite Oric Pharmaceuticals and Erasca positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oric Pharmaceuticals position performs unexpectedly, Erasca can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erasca will offset losses from the drop in Erasca's long position.

The idea behind Oric Pharmaceuticals and Erasca Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.